tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rohin Patel, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst Rohin Patel, currently employed at JPMORGAN, carries an average stock price target met ratio of 66.67% that have a potential upside of 11.37% achieved within 62 days.
Rohin Patel’s has documented 6 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HAE, Haemonetics at 12-Dec-2025.
Analyst best performing recommendations are on HAE (HAEMONETICS).
The best stock recommendation documented was for HAE (HAEMONETICS) at 12/12/2025. The price target of $74 was fulfilled within 34 days with a profit of $9.49 (11.37%) receiving and performance score of 3.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2024
$84
$6.71 (8.68%)
$84
18 days ago
(26-Jun-2026)
1/10 (10%)
$6.71 (8.68%)
125
Buy Since 26-Nov-2013
$85
$7.71 (9.98%)
$70
29 days ago
(15-Jun-2026)
21/37 (56.76%)
$8.09 (10.52%)
282
Hold Since 06-Feb-2026
$70
$-7.29 (-9.43%)
$70
1 months 16 days ago
(28-May-2026)
18/19 (94.74%)
$2.96 (4.42%)
128
Hold Since 11-Sep-2024
$80
$2.71 (3.51%)
$68
1 months 22 days ago
(22-May-2026)
2/3 (66.67%)
$14.51 (22.16%)
43
Buy Since 20-Apr-2021
$89
$11.71 (15.15%)
$94
2 months 2 days ago
(12-May-2026)
23/40 (57.5%)
$34.99 (64.78%)
299
What Year was the first public recommendation made by Rohin Patel?
